Literature DB >> 15867353

The p53 protein is a novel substrate of ribosomal S6 kinase 2 and a critical intermediary for ribosomal S6 kinase 2 and histone H3 interaction.

Yong-Yeon Cho1, Zhiwei He, Yiguo Zhang, Hong Seok Choi, Feng Zhu, Bu Young Choi, Bong Seok Kang, Wei-Ya Ma, Ann M Bode, Zigang Dong.   

Abstract

The tumor suppressor p53 protein is one of the most highly connected nodes in cellular signal transduction pathways and acts as a central regulatory switch in networks controlling cell proliferation and apoptosis. It is involved in the activation of genes that maintain control over cellular responses to DNA errors such as DNA repair, chromosomal recombination, and chromosome segregation. Here we show that ribosomal S6 kinase 2 (RSK2) activates and phosphorylates p53 (Ser15) in vitro and in vivo and colocalizes with p53 in the nucleus. Deficiency of p53 diminishes RSK2-mediated phosphorylation of histone H3 (Ser10) and adding back p53 to p53-/- embryonic fibroblasts restored phosphorylation of histone H3 at Ser10. These results show that the p53 protein is an important substrate of RSK2 and a critical intermediary in the RSK2 and histone H3 interaction. The RSK2-p53-histone H3 complex may likely contribute to chromatin remodeling and cell cycle regulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15867353     DOI: 10.1158/0008-5472.CAN-04-3935

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  Splicing of mouse p53 pre-mRNA does not always follow the "first come, first served" principle and may be influenced by cisplatin treatment and serum starvation.

Authors:  Min Yang; Jack Wu; Si-Hung Wu; An-Ding Bi; D Joshua Liao
Journal:  Mol Biol Rep       Date:  2012-06-28       Impact factor: 2.316

2.  Mitotic lymphoma cells are characterized by high expression of phosphorylated ribosomal S6 protein.

Authors:  Gábor Egervári; Agnes Márk; Melinda Hajdu; Gábor Barna; Zoltán Sápi; Tibor Krenács; László Kopper; Anna Sebestyén
Journal:  Histochem Cell Biol       Date:  2011-03-20       Impact factor: 4.304

3.  Phosphorylation of caspase-8 (Thr-263) by ribosomal S6 kinase 2 (RSK2) mediates caspase-8 ubiquitination and stability.

Authors:  Cong Peng; Yong-Yeon Cho; Feng Zhu; Jishuai Zhang; Weihong Wen; Yanming Xu; Ke Yao; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

4.  RSK2 mediates muscle cell differentiation through regulation of NFAT3.

Authors:  Yong-Yeon Cho; Ke Yao; Ann M Bode; H Robert Bergen; Benjamin J Madden; Sang-Muk Oh; Svetlana Ermakova; Bong Seok Kang; Hong Seok Choi; Jung-Hyun Shim; Zigang Dong
Journal:  J Biol Chem       Date:  2007-01-09       Impact factor: 5.157

5.  Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.

Authors:  Kangdong Liu; Yong-Yeon Cho; Ke Yao; Janos Nadas; Dong Joon Kim; Eun-Jin Cho; Mee-Hyun Lee; Angelo Pugliese; Jishuai Zhang; Ann M Bode; Ziming Dong; Zigang Dong
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

6.  Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation.

Authors:  Duo Zheng; Yong-Yeon Cho; Andy T Y Lau; Jishuai Zhang; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

7.  Role of NEK6 in tumor promoter-induced transformation in JB6 C141 mouse skin epidermal cells.

Authors:  Young Jin Jeon; Kun Yeong Lee; Yong-Yeon Cho; Angelo Pugliese; Hong Gyum Kim; Chul-Ho Jeong; Ann M Bode; Zigang Dong
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

8.  RSK2 mediates NF-{kappa}B activity through the phosphorylation of IkappaBalpha in the TNF-R1 pathway.

Authors:  Cong Peng; Yong-Yeon Cho; Feng Zhu; Yan-Ming Xu; Weihong Wen; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  FASEB J       Date:  2010-04-12       Impact factor: 5.191

9.  Kaempferol targets RSK2 and MSK1 to suppress UV radiation-induced skin cancer.

Authors:  Ke Yao; Hanyong Chen; Kangdong Liu; Alyssa Langfald; Ge Yang; Yi Zhang; Dong Hoon Yu; Myoung Ok Kim; Mee-Hyun Lee; Haitao Li; Ki Beom Bae; Hong-Gyum Kim; Wei-Ya Ma; Ann M Bode; Ziming Dong; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-03

10.  Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2.

Authors:  Margarita Malakhova; Igor Kurinov; Kangdong Liu; Duo Zheng; Igor D'Angelo; Jung-Hyun Shim; Valerie Steinman; Ann M Bode; Zigang Dong
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.